Langer Lab company gets $5M in funding for drug-delivery device

Langer Lab startup SQZ Biotech raised $5 million in a Series A round led by Polaris Venture Partners to support its method to gain entry into a cell's membrane by first squeezing it through a device. SQZ touts it as a replacement for viral vectors. More from FierceBiotech